UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028099
Receipt number R000032149
Scientific Title Observational epidemiology database study on cognitive behavioral therapy of the anxiety disorder
Date of disclosure of the study information 2017/07/06
Last modified on 2017/07/05 15:42:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational epidemiology database study on cognitive behavioral therapy of the anxiety disorder

Acronym

Database study on cognitive behavioral therapy of the anxiety disorder

Scientific Title

Observational epidemiology database study on cognitive behavioral therapy of the anxiety disorder

Scientific Title:Acronym

Database study on cognitive behavioral therapy of the anxiety disorder

Region

Japan


Condition

Condition

anxiety disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

For the patients who received cognitive behavioral therapy of the anxiety disorder (social anxiety disorder(SAD), panic disorder(PD), obsessive compulsive disorder(OCD), PTSD), I collect the symptom with the structured interview and writing by oneself-style question paper and observational epidemiology data of the evaluation standard score of the QOL in the form that a study cooperator providing cognitive behavioral therapy inputs into WEB database and am intended that I analyze it in the place where enough majority cases gathered about the progress.
It is with valuable data for the spread if I can fix the system chasing the progress of the patient who received cognitive-behavioral therapy of the anxiety disorder by this study and thinks that it is significant.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Patient Health Questionnaire-9 :PHQ-9
Generalized Anxiety Disorder-7 :GAD-7
Working Alliance Inventory Short Form:WAI-SF

The main diagnosis
OCD: Yale-Brown Obsessive-Compulsive Scale :Y-BOCS
SAD: Liebowitz Social Anxiety Scale :LSAS
PD: Panic Disorder Severity Scale :PDSS
PTSD: Impact of Event Scale-Revised:IES-R

An investigation period is one year per one patient. The data are collected with following four points,from the point of the cognitive behavioral therapy of start, a midterm, the point of end, a start one year later.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1 Correspond to obsessive-compulsive disorder, panic disorder, society anxiety disorder, diagnostic criteria of the PTSD
:mental disease simple posture Creator interview The Mini-International Neuropsychiatric Interview:M.I.N.I. is based.

2 The age at agreement acquisition is less than 65 years old 16 years old or older. The sex does not matter.

3 A document agreement:give the case younger than 20 years to the person 16 years old or older, and the document of the protector agrees; by the free will of the person is provided in the one which understands it enough after having received enough explanation on participating of the final examination.

4 Can understand cognitive-behavioral therapy, and, for at least one year, can practice it continuously; is mental, and have a physical state.

5 Previous treatment, having medical therapy or not do not matter

Key exclusion criteria

1 The person that I am complicated with serious mental disorders such as the brain disorder (including dementia) of the tissue, a psychotic obstacle, bipolar disorder, the drug dependency, and interruption of the cognitive-behavioral therapy is expected for these symptom aggravation.
2 The person that interruption of the cognitive-behavioral therapy is expected to have the risk of the urgent suicide.
3 The person that interruption of the cognitive-behavioral therapy is expected because I repeat an antisocial act.
4 The person that interruption of the cognitive-behavioral therapy is expected to have a serious progressive physical disease.
5 The person who has difficulty in contact with the researcher.
6 The person who, in addition, judged it though a study person in charge or a study partaker carried out the final examination safely if was inappropriate.

Target sample size

210


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Eiji Shimizu

Organization

Graduate School of Medicine Chiba University,Chiba University Hospital

Division name

Research Center for Child Mental Development, Department of Cognitive Behavioral Physiology,Cognitive Behavioral Therapy Center

Zip code


Address

1-8-1 Inohana, Chuouku, Chiba, Japan

TEL

043-226-2027

Email

eiji@faculty.chiba-u.jp


Public contact

Name of contact person

1st name
Middle name
Last name Eiji Shimizu

Organization

Graduate School of Medicine Chiba University

Division name

Department of Cognitive Behavioral Physiology

Zip code


Address

1-8-1 Inohana, Chuouku, Chiba, Japan

TEL

043-226-2027

Homepage URL


Email

eiji@faculty.chiba-u.jp


Sponsor or person

Institute

Graduate School of Medicine Chiba University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study design
A.A direction of the data acquisition: The kind of the forward ;that but I turn my back and am possible after having obtained consent from a patient when data already exist.

B. study: It is a study of running, a cohort study


Management information

Registered date

2017 Year 07 Month 06 Day

Last modified on

2017 Year 07 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032149


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name